<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2910246125
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Pneumovax 23 Pneumococcal Vaccine Polyvalent
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PNEUMOCOCCAL (STREPTOCOCCUS PNEUMONIAE) POLYSACCHARIDE (SEROTYPE 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F) 
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous, Subcutaneous
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        135.5
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MERCK SHARP AND DOHME LLC" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MERCK SHARP AND DOHME LLC
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MERCK SHARP AND DOHME LLC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J07AL01 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:3.1pt">PNEUMOVAX 23 is a pneumococcal vaccine. Vaccines are used to protect you or your child against infectious diseases. Your doctor has recommended that you or your child (two years of age and older) have the vaccine to help protect against severe infections caused by bacteria that are called pneumococci.<br />Pneumococci can cause infections of the lungs (especially pneumonia) and of the coverings over the brain and spinal cord (meningitis) and in the blood (bacteraemia or septicaemia). The vaccine will only be able to protect you or your child against pneumococcal infections that are due to the types of these bacteria that are included in the vaccine. However, the 23 pneumococcal types in the vaccine include those that cause almost all (about nine out of ten) infections caused by pneumococci.<br />When the vaccine is given to you or your child, the body&rsquo;s natural defences make antibodies that help to protect against pneumococcal infections.<br />Pneumococcal infections occur throughout the world and can occur in anyone at any age, but are most likely in:<br />&bull; elderly people.<br />&bull; people who have lost their spleen or whose spleen is not working.<br />&bull; people who have low resistance to infections due to longstanding illnesses or infections (such as heart disease, lung disease, diabetes mellitus, kidney disease, liver disease or HIV infection).<br />&bull; people who have low resistance to infections due to treatment that they have had for some illnesses (such as cancer).<br />Pneumococcal infections of the coverings of the brain and spinal cord (meningitis) sometimes occur after injuring and cracking the skull and very rarely after certain medical operations. The vaccine may not be able to prevent all of these infections.<br />Also, pneumococcal infections can occur in the sinuses, ears, and in other parts of the body. The vaccine is not thought likely to protect you or your child against these more minor kinds of infections.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:5.35pt">PNEUMOVAX 23 is for use only in persons who are at least two years old. This is because younger children do not reliably respond to the vaccine.<br />To make sure that the vaccine is suitable for you or your child, it is important to tell your doctor or nurse if any of the points below apply to you or your child. If there is anything you do not understand, or if you are not sure, ask your doctor or nurse to explain. As with other vaccines, PNEUMOVAX 23 may not fully protect all those who get it.<br />Do not use PNEUMOVAX 23 if you or your child are allergic (hypersensitive) to pneumococcal vaccine polyvalent or any of the ingredients that are listed in section 6.<br />Warnings and precautions<br />Talk to your doctor, pharmacist or nurse before vaccination if:<br />&bull; you or your child has an infection with a high temperature, as vaccination may need to be delayed until you or your child has recovered.<br />You should also tell your doctor before vaccination if:<br />&bull; you or your child has a low resistance to infections because of a course of treatment (such as drugs or radiation treatment for cancer).<br />&bull; you or your child has a longstanding illness or an infection that may have lowered resistance to pneumococcal infections.<br />In these cases vaccination may need to be delayed and even then it may not protect you as well as it protects healthy people.<br />Individuals aged 65 years and older may not tolerate medical interventions as well as younger individuals. Therefore a higher number and/or greater severity of reactions in some older individuals cannot be ruled out.<br />Other medicines and PNEUMOVAX 23<br />Tell your doctor or pharmacist if you or your child are using, have recently used or might use any other medicines.<br />PNEUMOVAX 23 can be given at the same time as influenza vaccine as long as different injection sites are used. Most people are able to respond to both vaccines at the same time so that they can be protected against both infections.<br />For information about the administration of PNEUMOVAX 23 and ZOSTAVAX at the same time, talk to your doctor or health care provider.<br />If you or your child are already taking antibiotics to prevent pneumococcal infection, these should not be stopped after vaccination. Also, even after having the vaccine, it is still important that you see a doctor and get antibiotic treatment quickly if you think that you or your child may have any type of infection and you or your child have been told that you have a high risk of getting a pneumococcal infection (for example, if you have no spleen or it is not working properly).<br />Pregnancy, breast-feeding and fertility<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby or to breast-feed, ask your doctor or pharmacist for advice before taking this vaccine.<br />Driving and using machines<br />There is no information to suggest that the vaccine will affect your ability to drive or use machines.<br />PNEUMOVAX 23 contains sodium<br />This medicine contains less than 1 mmol sodium (23 mg) per dosage unit, that is to say essentially sodium-free.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:2.45pt">The vaccination should be given by a doctor or nurse who has been trained in the use of vaccines. The vaccine should be given in a surgery or clinic because there is equipment to deal with any uncommon severe allergic reaction to the injection.<br />Always use this vaccine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.<br />The vaccine is given as an injection into a muscle or deep under the skin. Your doctor or nurse will avoid giving you or your child the injection either into the skin or into a blood vessel.<br />The vaccine is sometimes given before (usually at least two weeks before) the planned date for taking out your spleen or for starting special treatments for cancer. If you or your child have already started or have finished special treatments, the vaccine may be delayed for about three months.<br />When the vaccine is given to people who are HIV positive, it is usually given as soon as the test result is known.<br />You or your child will receive one dose of the vaccine. A second dose of the vaccine is not usually given until at least three years after the first dose. Healthy people do not usually need to have a second dose. However, for persons at increased risk of serious pneumococcal infection (such as those who have no spleen or a spleen that does not work properly), further doses of the vaccine may be recommended, usually between 3 and 5 years after the first dose. A repeat dose is not usually recommended within 3 years of the first dose due to a higher risk of side effects.<br />Your doctor or nurse will be able to decide if and when you or your child need a further dose of the vaccine.<br /><strong>If you use more PNEUMOVAX 23 than you should</strong><br />There have been no reports of overdose with the vaccine. Overdose is very unlikely because the vaccine is provided in single dose, pre-filled syringe and is given by a doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:36.65pt">Like all vaccines and medicines, PNEUMOVAX 23 can cause side effects, although not everybody gets them.<br />Allergic Reactions<br />You must seek urgent medical help if you or your child experience any of the symptoms, listed below, or other serious symptoms after vaccination:<br />&bull; difficulty in breathing, blue discolouration of the tongue or lips,<br />&bull; low blood pressure (causing dizziness) and collapse,<br />&bull; fever, generally feeling unwell with pains or even inflammation and swelling in the joints and muscle pain,<br />&bull; swelling of the face, lips, tongue and/or throat and neck,<br />&bull; swelling of the hands, feet or ankles,<br />&bull; hives (inflamed wheals on the skin) and rashes.<br />If serious allergic reactions occur, they often do so very soon after the injection, while still in the clinic.<br />Side Effects<br />The most common reactions (may affect more than 1 in 10 people) reported are soreness, pain, redness, warmth, swelling and hardening at the injection site, and fever. These reactions tend to be more common after the second dose of the vaccine than after the first dose.<br />Other side effects include:<br />Rare (may affect up to 1 in 1,000 people):<br />&bull; extensive swelling of the vaccinated limb.<br />Not known (frequency cannot be estimated from the available data):<br />&bull; decreased mobility of the injected limb,<br />&bull; feeling tired,<br />&bull; feeling generally unwell,<br />&bull; uncontrollable shivering,<br />&bull; feeling sick or being sick,<br />&bull; enlarged and/or inflamed glands,<br />&bull; pain, inflammation and swelling of the joints and muscle pains,<br />&bull; a drop in the number of certain types of particles in the blood called platelets in people who already have low numbers of these due to another illness called ITP that causes a higher risk of bleeding and bruising,<br />&bull; headache, altered skin sensation or pins and needles, decreased limb mobility, numbness and weakness of the legs and arms (including an illness called Guillain-Barr&eacute; syndrome),<br />&bull; an increase in the value of a blood test that is a measure of inflammation in the body (C-reactive protein (CRP)),<br />&bull; patients who have had blood disorders may develop destruction of red blood cells leading to an inadequate number of red blood cells (haemolytic anaemia),<br />&bull; an increase in the number of certain types of white blood cells,<br />&bull; a fit (convulsion) associated with a high temperature.<br />Reporting of side effects<br />If you or your child get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. This includes any possible side effects not listed in this leaflet.<br />You can also report side effects directly via The National Pharmacovigilance and Drug Safety Centre (NPC), SFDA. By reporting side effects, you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:-1.0pt">Keep this vaccine out of the sight and reach of children.<br />Do not use this vaccine after the expiry date which is stated on the box after EXP. The expiry date is written on both outer back &amp; inner label.<br />Store in a refrigerator (2&deg;C - 8&deg;C). Do not freeze.<br />Your doctor or nurse will check that the liquid is clear and colourless and that there are no large particles in it before giving you or your child the vaccine.<br />Do not throw away any vaccines via wastewater or house hold waste. Ask your pharmacist how to throw away vaccines you no longer need. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="margin-left:5.9pt; margin-right:-1.0pt">What PNEUMOVAX 23 contains<br />0.5 millilitre dose contains the following:<br />&bull; Active ingredients - 25 micrograms (a very small amount) of each of 23 types of polysaccharide from bacteria known as pneumococci. The 23 types of pneumococcal polysaccharide in the vaccine are types 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F and 33F.<br />&bull; Other ingredients &ndash; phenol, liquified special (1.25 mg), sodium chloride (4.5 mg) and water for injections (0.5 ml).<br />&bull;<br />The vaccine contains less than 1 mmol sodium (23 mg) per dose, i.e. essentially &lsquo;sodium-free&rsquo;.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
It is provided as a solution for injection in pre-filled syringe (0.5 mL).
It is available in pack containing 1 or 10 pre-filled syringes without needle.
It is available in pack containing 1 or 10 pre-filled syringes with 1 separate needle.
It is available in pack containing 1 or 10 pre-filled syringes with 2 separate needles.
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Merck, Sharp &amp; Dohme LLC, 770 Sumneytown Pike,<br />P.O. Box 4, West Point, PA 19486, US.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised on Dec 2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">نيموفاكس 23 هو لُقاح مضاد للمكورات الرئوية متعدد التكافؤ. تستخدم اللقاحات لحمايتك أو لحماية طفلك ضد الأمراض المعدية. وقد أوصی طبیبك بأن تتلقّى أنت أو طفلك (بدءًا من عمر سنتین أو أکبر) اللقاح للمساعدة في الحمایة من الإلتهابات الشدیدة الناجمة عن البکتیریا التي تسمی المکورة الرئویة.</p><p dir="RTL">يمكن أن تسبب المكورات الرئوية التهابات في الرئتين (وخاصة الالتهاب الرئوي) وغشاء الدماغ والحبل الشوكي (التهاب السحايا) وفي الدم ( تجرثم الدم أو تسمم الدم). يتمكن اللقاح من حمايتك أنت أو طفلك من الالتهابات الرئوية التي تسببها أنواع هذه البكتيريا المشمولة في اللقاح. ومع ذلك، فإن أنواع المكورات الرئوية 23 في اللقاح تشمل تلك التي تُسبب تقريبًا جميع (حوالي تسعة من أصل عشرة) أنواع العدوى الناجمة عن المكورات الرئوية.</p><p dir="RTL">عندما تتلقى اللقاح أنت أو طفلك، تبدأ الدفاعات الطبيعية في جسدك بتصنيع الأجسام المضادة التي تساعد على حمايتك ضد العدوى بالمكورات الرئوية.</p><p dir="RTL">تحدث الالتهابات بالكورات الرئوية في جميع أنحاء العالم ويمكن أن تحدث لدى أي شخص وفي أي عمر، لكنها تحدث على الأرجح لدى:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كبار السن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأشخاص الذين فقدوا طحالهم أو الذين لا يعمل الطحال لديهم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأشخاص الذين لديهم مقاومة منخفضة للإصابة بالإلتهابات لوجود أمراض أو التهابات مزمنة لديهم (مثل أمراض القلب، وأمراض الرئة، وداء السكري، وأمراض الكلى، وأمراض الكبد أو عدوى فيروس نقص المناعة&nbsp; البشرية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأشخاص الذين لديهم مقاومة منخفضة للإصابة بالإلتهابات بسبب العلاجات الذين تلقوها لعلاج بعض الأمراض (مثل السرطان).</p><p dir="RTL">تحدث العدوى بالمكورات الرئوية في أغشية الدماغ والحبل الشوكي (التهاب السحايا) أحيانا بعد إصابة وتشقق الجمجمة وقد تحدث بشكل نادر جدًّا بعد بعض العمليات الطبية. قد لا يتمكن اللقاح من منع حدوث جميع هذه الإلتهابات.</p><p dir="RTL">كما يمكن أن تحدث الالتهابات بالمكورات الرئوية في الجيوب الأنفية والأذنين، وفي أجزاء أخرى من الجسم. لا يُعتقد أن يحميك اللقاح أنت أو طفلك من هذه الأنواع البسيطة من الالتهابات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">نيموفاكس 23 مُعد للاستخدام لدى الأشخاص الذين لا تقل أعمارهم عن سنتين. وذلك لأن الأطفال الأصغر سنًا لا يستجيبون بشكل موثوق لللقاح.</p><p dir="RTL">كي تتأكد من أن اللقاح مناسب لك أو لطفلك، من المهم إخبار طبيبك أو ممرضتك إذا كان أي من النقاط أدناه ينطبق عليك أو على طفلك. إذا استعصى عليك فهم أي منها، أو إذا كنت غير متأكد، اطلب من الطبيب أو الممرض المزيد من الشرح. وكما هو الحال مع اللقاحات الأخرى، قد لا يحمي نيموفاكس 23 كل الذين يحصلون عليه بشكل كامل.</p><p dir="RTL"><strong>لا تستخدم نيموفاكس 23 </strong>إذا كان لديك أو لدى طفلك حساسية (رد فعل تحسّسي) نحو لقاح المكورات الرئوية متعدد التكافؤ أو نحو أي من المكونات المذكورة في القسم 6.</p><p dir="RTL"><strong>المحاذير والإحتياطات</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي أو الممرض قبل التطعيم إذا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مصابًا أنت أو طفلك بعدوى مصحوبة بحمى، إذ قد يستلزم الأمر تأخير التطعيم حتى تستعيد أنت أو طفلك عافيتك.</p><p dir="RTL">يجب عليك أيضا إخبار طبيبك قبل التطعيم إذا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كانت مقاومتك أنت أو طفلك للإلتهابات منخفضة بسبب أحد العلاجات (مثل الأدوية أو العلاج الإشعاعي للسرطان).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مصابًا أنت أو طفلك بمرض طويل الأمد أو عدوى أدّت إلى تدني مقاومتك للعدوى بالمكورات الرئوية.</p><p dir="RTL">في مثل هذه الحالات قد يستلزم الأمر تأخير التطعيم، وحتى عندها قد لا يؤمن لك التطعيم الوقاية كما يؤمنها للأفراد الأصحاء.</p><p dir="RTL">قد لا يتحمّل الأفراد الذين تتراوح أعمارهم بين 65 عاما أو أكثر التدخلات الطبية كما يتحملها الأفراد الأصغر سنا. لذلك لا يمكن استبعاد حدوث ردود فعل بعدد أكبر و / أو بشدة أكثر لدى البعض منهم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية أخرى ونيموفاكس 23</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت أنت أو طفلك تستخدم، قد استخدمت مؤخرا أو قد تستخدم أي أدوية أخرى.</p><p dir="RTL">يمكن إعطاء ونيموفاكس 23 في نفس الوقت مع لقاح الأنفلونزا طالما تم حقن كل منهما في موضعين مختلفين. معظم الناس قادرون على الاستجابة لكلا اللقاحين في نفس الوقت بحيث يمكن الحماية ضد العدوى بهما.</p><p dir="RTL">لمزيد من المعلومات حول إعطاء لقاح زوستافاكس مع&nbsp; نيموفاكس 23 &nbsp;، تحدث مع طبيبك أو مقدم الرعاية الصحية .</p><p dir="RTL">إذا كنت أنت أو طفلك تتناول بالفعل المضادات الحيوية لمنع العدوى بالمكورات الرئوية، لا ينبغي التوقف عن تناولها بعد التطعيم. وكذلك، حتى بعد الحصول على اللقاح، لا يزال من المهم أن ترى الطبيب ليصف لك العلاج بالمضادات الحيوية بسرعة إذا كنت تعتقد أنك أو طفلك قد أُصبت بأي نوع من العدوى وأنك سبق لك العلم أنك أو طفلك مُعَرّض لخطر كبير في الإصابة بعدوى المكورات الرئوية (على سبيل المثال، إذا لم يكن لديك طحال أو أنه لا يعمل بشكل صحيح).</p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">إذا كنت حاملًا أو مرضعة، تعتقد أنك قد تكونين حاملًا أو تخططين للحمل&nbsp; أو لإرضاع طفلك الرضاعة الطبيعية ، استشيري طبيبك أو الصيدلي قبل تلقّي هذا اللقاح.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا توجد معلومات تشير إلى أن اللقاح سوف يؤثر على قدرتك على القيادة أو استخدام الآلات.</p><p dir="RTL"><strong>يحتوي</strong><strong> </strong><strong>نيموفاكس 23 على</strong><strong> </strong><strong>الصوديوم</strong></p><p dir="RTL">&nbsp;يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 ملغم) لكل جرعة ، أي أنه خالي من الصوديوم بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ينبغي إعطاء التطعيم من قبل طبيب أو ممرض تم تدريبه على إعطاء اللقاحات. يجب إعطاء اللقاح في غرفة الجراحة أو العيادة لأنها تحتوي على المعدات اللازمة للتعامل مع أي رد فعل تحسسي شديد غير شائع نتيجة الحقن.</p><p dir="RTL">استخدم هذا اللقاح دائما كما أرشدك الطبيب أو الصيدلي بالضبط. تحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">يُعطى اللّقاح كحقنة في العضل أو عميقة تحت الجلد. سيتجنّب طبيبك أو ممرضتك إعطاءك أو طفلك الحقن إما في الجلد أو في وعاء دموي.</p><p dir="RTL">يتم إعطاء اللقاح أحيانا قبل الموعد المحدد لإزالة الطحال الخاص بك أو لبدء العلاجات الخاصة للسرطان (عادة قبل أسبوعين على الأقل). إذا كنت أنت أو طفلك قد بدأت بالفعل أو أنهيت العلاجات الخاصة، قد يتأخر اللقاح لمدة ثلاثة أشهر تقريبا.</p><p dir="RTL">عندما يُعطى اللقاح للأشخاص المصابين بفيروس نقص المناعة البشرية، فإنه عادة ما يعطى حالما تصبح نتيجة الاختبار معروفة.</p><p dir="RTL" style="text-align:right">ستتلقى أنت أو طفلك جرعة واحدة من اللقاح. ولا تعطى الجرعة الثانية من اللقاح عادة إلا بعد مرور ثلاث سنوات على الأقل من الجرعة الأولى. فالأشخاص الأصحاء لا يحتاجون عادة إلى جرعة ثانية. ولكن، بالنسبة للأشخاص المعرضين لخطر الإصابة بعدوى المكورات الرئوية الخطيرة (مثل أولئك&nbsp;الذين ليس لديهم طحال أو أن الطحال لا يعمل بشكل صحيح)، يمكن التوصية بمزيد من الجرعات من اللقاح، وعادة ما تكون بين 3 و 5 سنوات بعد الجرعة الأولى. لا يُنصح عادة بإعطاء الجرعة المتكررة في غضون 3 سنوات من الجرعة الأولى بسبب ارتفاع مخاطر الآثار الجانبية.</p><p dir="RTL">سیقرر طبیبك أو ممرضك إذا کنت أنت أو طفلك بحاجة إلی جرعة إضافیة من اللقاح.</p><p dir="RTL"><strong>إذا كنت تستخدم نيموفاكس 23 أكثر مما يجب</strong></p><p dir="RTL">لم ترد تقارير عن تلقي جرعة زائدة من اللقاح. من المستبعد جدا تلقي جرعة زائدة لأن اللقاح يتوفر على شكل حقنة مسبقة التعبئة تحتوي على جرعة واحدة مسبقا ويعطى من قبل طبيب أو ممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">وعلى غرار جميع اللقاحات والأدوية، يمكن أن يسبب نيموفاكس 23 مضاعفات جانبية، وإن كانت لا تحدث لدى جميع من يتلقاه.</p><p dir="RTL"><strong>التفاعلات التحسسيّة<br />يجب عليك طلب المساعدة الطبية العاجلة إذا تعرضت أنت أو طفلك لأي من الأعراض المذكورة أدناه أو أعراض خطيرة أخرى بعد التطعيم،</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس، وتغير لون اللسان أو الشفاه إلى الأزرق ،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض ضغط الدم (يُسبب الدوخة) والهبوط،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى، والشعور العام بالإعياء مع آلام أو حتى التهاب وتورم في المفاصل وآلام في العضلات،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في الوجه والشفتين واللسان و / أو الحنجرة والرقبة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم في اليدين أو القدمين أو الكاحلين،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشرى (الشقوق الملتهبة على الجلد) والطفح الجلدي.</p><p dir="RTL">إذا حدثت ردود فعل تحسسية خطيرة، فإنها غالبا ما تحدث بعد الحقن بوقت قريب جدا ، أثناء التواجد في العيادة.</p><p dir="RTL"><strong><u>الآثار الجانبية</u></strong></p><p dir="RTL">تتضمن ردود الفعل الأكثر شيوعا (قد تؤثر على أكثر من شخص من بين 10 أشخاص) تقرّح، وألم، واحمرار، ودفء، وتورم وتصلب موضع الحقن، والحمى. تميل هذه التفاعلات إلى أن تكون أكثر شيوعًا بعد الجرعة الثانية عن الجرعة الأولى.</p><p dir="RTL">وتشمل الآثار الجانبية الأخرى:</p><p dir="RTL">نادر (قد تؤثر على ما يصل إلى شخص من بين 1000 شخص):</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم واسع النطاق في الطرف الذي تم الحقن فيه.</p><p dir="RTL">غير معروف (لا يمكن تقدير تكرار حدوثها من البيانات المتاحة):</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; محدودية الحركة في الطرف الذي تم الحقن فيه،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور العام بالتعب،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوعك عموما،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الارتعاش الخارج عن السيطرة،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالمرض أو المرض،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورّم و / او التهاب الغدد،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم، التهاب وتورم في المفاصل وآلام العضلات،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد أنواع معينة من الجسيمات في الدم تسمى الصفائح الدموية لدى الأشخاص الذين لديهم&nbsp; بالفعل عدد قليل من هذه الجسيمات بسبب مرض آخر يسمى آي تي بي ITP الذي يُسبب خطر أعلى من النزيف والكدمات،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع أو تغيير في الإحساس بالجلد أو وخز وتنميل، وتدني حركة الأطراف، وخدر وضعف في الساقين والذراعين (بما في ذلك مرض يسمى متلازمة غيلان-باريه)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في نتيجة فحص الدم الذي يقيس مقدار الالتهاب في الجسم ( البروتين التفاعلي- c (CRP))،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المرضى الذين يعانون من اضطرابات في الدم قد يواجهون تدمير لخلايا الدم الحمراء مما يؤدي إلى تدني في عدد خلايا الدم الحمراء (فقر الدم الانحلالي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في عدد أنواع معينة من خلايا الدم البيضاء،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبة(التشنج) المرتبطة بارتفاع درجة الحرارة.</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا شعرت أنت أو طفلك بأي آثار جانبية، تحدث مع طبيبك أو الصيدلي أو الممرض. وهذا يشمل أي آثار جانبية محتملة غير مدرجة في هذه النشرة.</p><p dir="RTL">يمكنك أيضا الإبلاغ عن الآثار الجانبية مباشرة عن طريق المركز الوطني للتيقظ &nbsp;والسلامة الدوائية (إن بي سي NPC) ، الهيئة العامة للغذاء والدواء &ndash; المملكة العربية السعودية. من خلال الإبلاغ عن الآثار الجانبية ، يمكنك المساعدة في تقديم المزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا اللقاح بعيدا عن مرأى ومتناول الأطفال.<br />لا تستخدم هذا اللقاح بعد تاريخ انتهاء الصلاحية المُدوّن على العلبة بعد EXP. تاريخ انتهاء الصلاحية مُدوّن على كل من العلبة الخارجية والملصق الداخلي.</p><p dir="RTL">يُحفظ في الثلاجة في درجة حرارة (8-2 درجة مئويّة). لا يُجمد.</p><p dir="RTL">سيقوم طبيبك أو ممرضك بالتحقق من أن السائل صافٍ لا لون له وأنه لا توجد جزيئات كبيرة فيه قبل إعطائه لك أو لطفلك.</p><p dir="RTL">لا تتخلص من أي لقاحات عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من اللقاحات التي لم تعد بحاجة إليها. وستساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تحتوي الجرعة <strong>0.</strong>5&nbsp; ملليلتر على ما يلي:</p><p dir="RTL">المكونات الفعالة - 25 ميكروغرام (كمية صغيرة جدا) من كل من 23 نوع من السكاريد المُتعدد من البكتيريا المعروفة باسم المكورات الرئوية. أنواع 23 من سكاريد المُتعدد المكورات الرئوية الموجودة في اللقاح هي 1، 2، 3، 4، 5، 6 بي، 7 إف، 8، 9 إن، 9 في، 10 أي، 11 أي، 12 إف، 14، 15 بي، 17 إف، 18 سي، 19 إف، 19 أي، 20 ، 22 إف، 23 إف و 33 &nbsp;إف.</p><p dir="RTL">&bull; المكونات الأخرى - الفينول، المُسال الخاص (1.25 &nbsp;ملغم)، كلوريد الصوديوم (4.5&nbsp; ملغم) والماء المُخًصص للحقن (0.5 ملل).</p><p dir="RTL">يحتوي اللقاح على أقل من 1 مليمول من الصوديوم (23 ملغم) في كل جرعة، أي &quot;خال من الصوديوم&quot;.&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>ما &nbsp;شكل نيموفاكس 23 ووصفه وحجم عبوته </strong><br />يتوفر اللقاح على شكل محلول للحقن في حقنة مُسبقة التعبئة (0.5 ملل).<br />وهو متوفر في عُلب تحتوي على 1 أو 10 محاقن مُسبقة التعبئة دون إبرة.<br />وهو متوفر في عُلب تحتوي على 1 أو 10 محاقن مُسبقة التعبئة مع إبرة واحدة منفصلة.<br />وهو متوفر في عُلب تحتوي على 1 أو 10 محاقن مُسبقة التعبئة مع إبرتين منفصلتين.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة ميرك شارب و دوهم ذ م م<br />770 سومنيتون ﺑﺎي ك<br />ص ب 4<br />ويست بوينت، بي إيه 19486&nbsp;الولايات المتحدة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت الموافقة على هذه النشرة بتاريخ ديسمبر 2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pneumovax® 23 (Pneumococcal Vaccine Polyvalent).
0.5 mL solution for injection in pre-filled syringes.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The 0.5 mL dose of vaccine contains 25 micrograms of each of the following 23 pneumococcal polysaccharide serotypes: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, 33F.
Excipient(s) with known effect
Sodium less than 1 mmol (23 mg) per dosage unit.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection in pre-filled syringe.
The vaccine is a clear, colourless solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:2.95pt; text-align:justify">Pneumococcal vaccine polyvalent is recommended for active immunisation against pneumococcal disease in children aged from 2 years, adolescents and adults.<br />See section 5.1 for information on protection against specific pneumococcal serotypes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:-1.0pt">The immunisation schedules for Pneumococcal vaccine polyvalent should be based on official recommendations.<br />Posology<br />Primary vaccination:<br />Adults and children of 2 years of age or older- one single dose of 0.5 millilitre by intramuscular or subcutaneous injection. Pneumococcal vaccine polyvalent is not recommended for use in children below 2 years of age as the safety and efficacy of the vaccine have not been established and the antibody response may be poor.<br />Special dosing:<br />It is recommended that pneumococcal vaccine should preferably be given at least two weeks before elective splenectomy or the initiation of chemotherapy or other immunosuppressive treatment. Vaccination during chemotherapy or radiation therapy should be avoided.<br />Following completion of chemotherapy and/or radiation therapy for neoplastic disease, immune responses to vaccination may remain diminished. The vaccine should not be administered any sooner than three months after completion of such therapy. A longer delay may be appropriate for patients who have received intensive or prolonged treatment (see section 4.4).<br /><br />Persons with asymptomatic or symptomatic HIV infection should be vaccinated as soon as possible after their diagnosis is confirmed.<br />Revaccination:<br />One single dose of 0.5 millilitre by intramuscular or subcutaneous injection.<br />The specific timing of, and need for, revaccination should be determined on the basis of available official recommendations.<br />See section 5.1 for information on immune responses following revaccination.<br />Revaccination at an interval of less than three years is not recommended because of an increased risk of adverse reactions. The rates of local and, in persons aged &ge;65 years, some systemic reactions have been shown to be higher after revaccination than after primary vaccination when three to five years have elapsed between doses. See section 4.8.<br />There are very limited clinical data regarding administration of more than two doses of Pneumococcal vaccine polyvalent.<br />Adults<br />Healthy adults should not be revaccinated routinely.<br />Revaccination may be considered for persons at increased risk of serious pneumococcal infection who were given pneumococcal vaccine more than five years earlier or for those known to have a rapid decline in pneumococcal antibody levels. For selected populations (e.g., asplenics) who are known to be at high risk of fatal pneumococcal infections, revaccination at three years may be considered.<br />Children<br />Healthy children should not be revaccinated routinely.<br />Children of 10 years of age and over<br />May be considered for revaccination according to the adult recommendation (see above).<br />Children between the ages of 2 and 10 years<br />Should only be considered for revaccination after 3 years if they are at high risk of pneumococcal infection (e.g., those with nephrotic syndrome, asplenia or sickle cell disease).<br />Method of administration<br />A dose of 0.5 mL from a single-dose of Pneumococcal vaccine polyvalent is to be injected intramuscularly (IM) or subcutaneously (SC).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:2.15pt">Delay the use of the vaccine in any significant febrile illness, other active infection or when a systemic reaction would pose a significant risk except when this delay may involve even greater risk.<br />Pneumococcal vaccine polyvalent should never be injected intravascularly, and precautions should be taken to make sure the needle does not enter a blood vessel. Also, the vaccine should not be injected intradermally, as injection by that route is associated with increased local reactions.</p><p style="margin-left:5.9pt; margin-right:2.15pt">If the vaccine is administered to patients who are immunosuppressed due to either an underlying condition or medical treatment (e.g., immunosuppressive therapy such as cancer chemotherapy or radiation therapy), the expected serum antibody response may not be obtained after a first or second dose. Accordingly, such patients may not be as well protected against pneumococcal disease as immunocompetent individuals.<br />As with any vaccine, vaccination with Pneumococcal vaccine polyvalent may not result in complete protection in all recipients.<br />For patients receiving immunosuppressive therapy, the time to recovery of the immune response varies with the illness and the therapy. Significant improvement in antibody response has been observed for some patients during the two years following the completion of chemotherapy or other immunosuppressive therapy (with or without radiation), particularly as the interval between the end of treatment and pneumococcal vaccination increased (see section 4.2).<br />As with any vaccine, adequate treatment provisions including epinephrine (adrenaline) should be available for immediate use should an acute anaphylactic reaction occur.<br />Required prophylactic antibiotic therapy against pneumococcal infection should not be stopped after pneumococcal vaccination.<br />Patients at especially increased risk of serious pneumococcal infection (e.g., asplenics and those who have received immunosuppressive therapy for any reason), should be advised regarding the possible need for early antimicrobial treatment in the event of severe, sudden febrile illness.<br />Pneumococcal vaccine may not be effective in preventing infection resulting from basilar skull fracture or from external communication with cerebrospinal fluid.<br />A clinical study of primary vaccination and revaccination was conducted in 629 adults &ge;65 years of age and 379 adults 50 to 64 years of age. The data obtained suggested that the rates of injection site and systemic adverse reactions among subjects &ge;65 years of age were not higher than the rates amongst subjects 50 to 64 years of age. It should be noted that, in general, elderly individuals may not tolerate medical interventions as well as younger individuals; a higher frequency and/or a greater severity of reactions in some older individuals cannot be ruled out (see section 4.2).<br />Sodium<br />This medicinal product contains less than 1 mmol (23 mg) sodium per dosage unit and is considered to be essentially sodium-free.<br />Traceability<br />In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:6.7pt">Pneumococcal vaccine can be administered simultaneously with influenza vaccine as long as different needles and injection sites are used.<br />The concomitant use of PNEUMOVAX 23 and ZOSTAVAX resulted in reduced immunogenicity of ZOSTAVAX in a small clinical trial (see section 5.1). However, data collected in a large observational study did not indicate increased risk for developing herpes zoster after concomitant administration of the two vaccines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:-1.0pt">Pregnancy</p><p style="margin-left:5.9pt; margin-right:-1.0pt">Animal studies are insufficient with respect to effects on reproductive toxicity (see section 5.3). The vaccine should not be used during pregnancy unless clearly necessary (the potential benefit must justify any potential risk to the foetus).<br />Breast-feeding<br />It is unknown whether this vaccine is excreted in human milk. Caution should be exercised when it is administered to a nursing mother.<br />Fertility<br />The vaccine has not been evaluated in fertility studies.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">a. Summary of the safety profile<br />A clinical study of primary vaccination and revaccination was conducted in 379 adults 50 to 64 years of age and 629 adults &ge;65 years of age. The rate of overall injection site adverse reactions in the older revaccination group was comparable to the rate observed in the younger revaccination recipients. Injection site reactions occurred within 3 days of vaccination and typically resolved by day 5. The rate of systemic and vaccine related systemic reactions in the older revaccination group was comparable to the rate observed in the younger revaccination recipients. The most common systemic adverse events overall were as follows: asthenia/fatigue, myalgia and headache. Symptomatic treatment resulted in complete recovery in most cases.</p><p style="margin-left:0in; margin-right:0in">b. Tabulated list of adverse reactions<br />The table below summarises the frequencies of the adverse reactions that were reported with Pneumococcal vaccine polyvalent in clinical trials and/or post marketing surveillance, using the following convention: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to<br />&lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:90%"><tbody><tr><td><p>Adverse reactions</p></td><td><p>Frequency</p></td></tr><tr><td colspan="2"><p><em>Blood and the lymphatic system disorders</em></p></td></tr><tr><td><p>Haemolytic anaemia<sup>*</sup></p><p>Leukocytosis</p><p>Lymphadenitis</p><p>Lymphadenopathy</p><p>Thrombocytopenia<sup>**</sup></p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Immune system disorders</em></p></td></tr><tr><td><p>Anaphylactoid reactions</p><p>Angioneurotic oedema</p><p>Serum sickness</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Nervous system disorders</em></p></td></tr><tr><td><p>Febrile convulsions</p><p>Guillain-Barr&eacute; Syndrome</p><p>Headache</p><p>Paraesthesia</p><p>Radiculoneuropathy</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Gastrointestinal disorders</em></p></td></tr><tr><td><p>Nausea</p><p>Vomiting</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Skin and subcutaneous tissue disorders</em></p></td></tr><tr><td><p>Rash</p><p>Urticaria</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Musculoskeletal and connective tissue disorders</em></p></td></tr><tr><td><p>Arthralgia</p><p>Arthritis</p><p>Myalgia</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>General disorders and administration site conditions</em></p></td></tr><tr><td><p><em>Fever </em><em>(</em><em>&pound;</em><em>38</em><em>.8</em><em>&deg;</em><em>C)</em></p><p><em>&nbsp;</em></p><p>Injection site reactions:</p><ul><li>erythema</li><li>induration</li><li>pain</li><li>soreness</li><li>swelling</li><li>warmth</li></ul><p>&nbsp;</p></td><td><p>Very common</p></td></tr><tr><td><p>Extensive swelling of the vaccinated limb<sup>&dagger;</sup></p><p>&nbsp;</p></td><td><p>Rare</p></td></tr><tr><td><p>Asthenia</p><p>Chills</p><p>Fever</p><p>Injected limb mobility decreased</p><p>Malaise</p><p>Peripheral oedema<sup>&dagger;&dagger;</sup></p><p>&nbsp;</p></td><td><p>Not known</p></td></tr><tr><td colspan="2"><p><em>Investigations</em></p></td></tr><tr><td><p>C-reactive protein increased</p></td><td><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p><sup>*</sup> in patients who have had other haematologic disorders</p><p><sup>**</sup> in patients with stabilised idiopathic thrombocytopenic purpura</p><p><sup>&dagger;</sup> with short onset time from vaccine administration; defined by clinical review of cases reporting the preferred terms of extensive swelling of the vaccinated limb, injection site cellulitis and cellulitis, all of which described cellulitis-like reactions.&nbsp;</p><p><sup>&dagger;&dagger;</sup> in the injected extremity</p><p>&nbsp;</p><p><strong>c. Paediatric population</strong></p><p><strong>&nbsp;</strong></p><p>A clinical study was conducted to evaluate the safety and immunogenicity of Pneumococcal vaccine polyvalent in 102 individuals, including 25 subjects 2 to 17 years of age, 27 subjects 18 to 49 years of age, and 50 subjects 50 years of age and older. The type and severity of injection-site and systemic adverse reactions reported among children 2 to 17 years of age were comparable to those reported among adults 18 years of age and older. However, the proportions of subjects reporting injection-site and systemic adverse reactions were higher among subjects 2 to 17 years of age than those 18 years of age and older.</p><p>&nbsp;</p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Saudi Arabia: </u></p><p>The National Pharmacovigilance Centre (NPC):</p><p>Fax: +966-11-205-7662</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Other GCC States: </u></p><p>Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">Not applicable.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">5.1. Pharmacodynamic properties<br />Pharmacotherapeutic group: pneumococcal vaccines, pneumococcus, purified polysaccharides antigen, ATC code: J07AL01<br />The vaccine is prepared from purified pneumococcal capsular polysaccharide antigens derived from the 23 serotypes that account for approximately 90% of invasive pneumococcal disease types. The following pneumococcal capsular polysaccharides are included: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, 33F.<br />Immunogenicity<br />The presence of type-specific humoral antibodies is generally thought to be effective in preventing pneumococcal disease. A &ge;2-fold increase in antibody level following vaccination was associated with efficacy in clinical trials of polyvalent Pneumococcal vaccine polyvalent. However, the concentration of anti-capsular antibody required to protect against pneumococcal infection caused by any specific capsular type has not been established. Most persons aged &ge;2 years (85 to 95%) respond to vaccination by making antibody to most or all of the 23 pneumococcal polysaccharides in the vaccine. Bacterial capsular polysaccharides induce antibodies primarily by T-cell-independent mechanisms and elicit poor or inconsistent antibody responses in children aged &lt;2 years.<br />Antibodies can be detected by the third week following vaccination but may decline as soon as 3 to 5 years after vaccination and a more rapid decline may occur in some groups (e.g., children and the elderly).<br />Immune responses to eight of the polysaccharides in Pneumococcal vaccine polyvalent have been compared following administration of a single dose of vaccine or placebo. Four groups of subjects were entered as defined by age (50-64 years and &ge;65 years) and by prior vaccination status (no prior vaccination or 1 vaccination 3-5 years previously).<br />o Prior to vaccination, antibody levels were higher in the revaccination group than in the primary vaccination group.<br />o In the primary and revaccination groups the geometric mean antibody levels for each serotype increased from pre- to post-vaccination.<br />o The ratios in geometric mean antibody concentrations by serotype at day 30 between those who were revaccinated and those who were given primary vaccination ranged from 0.60-0.94 in the &ge;65 years group and from 0.62-0.97 for the group aged between 50-64 years.<br />The clinical relevance of the lower antibody responses observed on revaccination compared to primary vaccination is not known.</p><p style="margin-left:0in; margin-right:0in">In a double-blind, controlled clinical trial, 473 adults, 60 years of age or older, were randomised to receive a single dose of ZOSTAVAX either concomitantly (N=237), or nonconcomitantly (N=236) with 23-valent Pneumococcal vaccine polyvalent. At four weeks post-vaccination, the VZV- specific immune responses following concomitant use were not similar to the VZV-specific immune responses following nonconcomitant administration. However in a US effectiveness cohort study of 35,025 adults &ge;60 years old, no increased risk of herpes zoster (HZ) was observed in individuals who received ZOSTAVAX and 23-valent Pneumococcal vaccine polyvalent concomitantly (N=16,532) as compared to individuals receiving ZOSTAVAX one month to one year after 23-valent Pneumococcal vaccine polyvalent (N=18,493) in routine practice. The adjusted hazard ratio comparing the incidence rate of HZ in the two groups was 1.04 (95% CI, 0.92, 1.16) over a median follow-up of 4.7 years. The data do not indicate that concomitant administration of the two vaccines alters the effectiveness of ZOSTAVAX.<br />Efficacy<br />The efficacy of polyvalent Pneumococcal vaccine polyvalent was established for pneumococcal pneumonia and bacteraemia in randomised controlled trials that were conducted among novice gold miners in South Africa. The protective efficacy against pneumococcal pneumonia, the primary endpoint in these studies, was 76.1% with a 6-valent vaccine and 91.7% with a 12-valent preparation.<br />In trials conducted in populations for which the vaccine is indicated (see section 4.1), vaccine effectiveness was reported to be 50 to 70% (e.g., persons with diabetes mellitus, chronic cardiac or pulmonary disease, and anatomic asplenia).<br />One study found that vaccination was significantly protective against invasive pneumococcal disease caused by several individual serotypes (e.g., 1, 3, 4, 8, 9V, and 14). For other serotypes, the number of cases detected in this study were too small to draw conclusions about serotype specific protection.<br />The results from one epidemiologic study suggest that vaccination may provide protection for at least 9 years after receipt of the initial dose of vaccine. Decreasing estimates of effectiveness have been reported with increasing interval after vaccination, particularly among the very elderly (persons aged &ge;85 years).<br />The vaccine is not effective for the prevention of acute otitis media, sinusitis and other common upper respiratory tract infections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:50.85pt">Since Pneumococcal vaccine polyvalent is a vaccine, pharmacokinetic studies were not performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">No preclinical safety testing was performed using the vaccine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:-1.0pt"><br />Phenol, Liquified Special (1.25 mg)<br />Sodium chloride (4.5 mg)<br />Water for injections (0.5 ml)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:52.95pt">Store in a refrigerator (2&deg;C &ndash; 8&deg;C).<br />Do not freeze.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:0in; margin-right:0in">0.5 mL solution in pre-filled syringe (glass) with a plunger stopper (bromobutyl elastomer) and tip cap (isoprene bromobutyl blend-polyisoprene or styrene-butadiene rubber) without needle.<br />0.5 mL solution in pre-filled syringe (glass) with a plunger stopper (bromobutyl elastomer) and tip cap (isoprene bromobutyl blend-polyisoprene or styrene-butadiene rubber), with 1 separate needle.<br />0.5 mL solution in pre-filled syringe (glass) with a plunger stopper (bromobutyl elastomer) and tip cap (isoprene bromobutyl blend-polyisoprene or styrene-butadiene rubber), with 2 separate needles.<br />Pack size of 1 or 10.<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="margin-left:5.9pt; margin-right:-1.0pt">The normal appearance of the vaccine is a clear, colourless solution.<br />Parenteral products should be inspected visually for extraneous particulate matter and/or discolouration prior to administration. In the event of either being observed, discard the medicinal product.<br />The vaccine should be used directly as supplied; no dilution or reconstitution is necessary.<br />Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Merck, Sharp & Dohme LLC, 770 Sumneytown Pike,
P.O. Box 4, West Point, PA 19486, US.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dec 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>